492 related articles for article (PubMed ID: 22736314)
1. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
[TBL] [Abstract][Full Text] [Related]
3. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus.
Ding S; Liang Y; Zhao M; Liang G; Long H; Zhao S; Wang Y; Yin H; Zhang P; Zhang Q; Lu Q
Arthritis Rheum; 2012 Sep; 64(9):2953-63. PubMed ID: 22549634
[TBL] [Abstract][Full Text] [Related]
4. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
[TBL] [Abstract][Full Text] [Related]
5. Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity.
Herndon TM; Juang YT; Solomou EE; Rothwell SW; Gourley MF; Tsokos GC
Clin Immunol; 2002 May; 103(2):145-53. PubMed ID: 12027419
[TBL] [Abstract][Full Text] [Related]
6. miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation.
Xue F; Li H; Zhang J; Lu J; Xia Y; Xia Q
Genes Immun; 2013 Mar; 14(2):127-31. PubMed ID: 23303246
[TBL] [Abstract][Full Text] [Related]
7. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
[TBL] [Abstract][Full Text] [Related]
9. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
Guo Q; Chen XY; Su Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of interleukin 2 in SLE T cells.
Tenbrock K; Tsokos GC
Int Rev Immunol; 2004; 23(3-4):333-45. PubMed ID: 15204092
[TBL] [Abstract][Full Text] [Related]
11. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.
Fujii Y; Fujii K; Tanaka Y
Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.
Tang Y; Luo X; Cui H; Ni X; Yuan M; Guo Y; Huang X; Zhou H; de Vries N; Tak PP; Chen S; Shen N
Arthritis Rheum; 2009 Apr; 60(4):1065-75. PubMed ID: 19333922
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus.
Burgos P; Metz C; Bull P; Pincheira R; Massardo L; Errázuriz C; Bono MR; Jacobelli S; González A
J Rheumatol; 2000 Jan; 27(1):116-27. PubMed ID: 10648027
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal anti-double-stranded DNA antibodies cross-react with phosphoglycerate kinase 1 and inhibit the expression and production of IL-2 in activated Jurkat T cell line.
Luan HY; Tang SJ; Yang W; Tsai CY; Sun GH; Sun KH
Clin Immunol; 2006 Sep; 120(3):326-34. PubMed ID: 16857429
[TBL] [Abstract][Full Text] [Related]
15. Aberrant T cell expression of Ca2+ influx-regulated miRNAs in patients with systemic lupus erythematosus promotes lupus pathogenesis.
Lu MC; Yu CL; Chen HC; Yu HC; Huang HB; Lai NS
Rheumatology (Oxford); 2015 Feb; 54(2):343-8. PubMed ID: 25172935
[TBL] [Abstract][Full Text] [Related]
16. SiLEncing SLE: the power and promise of small noncoding RNAs.
Rigby RJ; Vinuesa CG
Curr Opin Rheumatol; 2008 Sep; 20(5):526-31. PubMed ID: 18698172
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
[TBL] [Abstract][Full Text] [Related]
18. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus.
Katsiari CG; Tsokos GC
Autoimmun Rev; 2006 Feb; 5(2):118-21. PubMed ID: 16431340
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNA-31 and microRNA-21 as regulatory biomarkers in the activation of T lymphocytes of Egyptian lupus patients.
Amr KS; Bayoumi FS; Elgengehy FT; Abdallah SO; Ahmed HH; Eissa E
Rheumatol Int; 2016 Nov; 36(11):1617-1625. PubMed ID: 27510529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
